Researchers have eliminated caged mosquitoes using ‘gene drive’ technology to spread a genetic modification that blocks female reproduction.
The team from Imperial College London were able to crash caged populations of the malaria vector mosquito Anopheles gambiae in only 7-11 generations.
This breakthrough shows that gene drive can work, providing hope in the fight against a disease that has plagued mankind for centuries
Professor Andrea Crisanti | Lead researcher
This is the first time experiments have been able to completely block the reproductive capacity of a complex organism in the laboratory using a designer molecular approach.
The technique, called gene drive, was used to selectively target the specific mosquito species An. gambiae that is responsible for malaria transmission in sub-Saharan Africa. There are around 3500 species of mosquito worldwide, of which only 40 related species can carry malaria.
The hope is that mosquitoes carrying a gene drive would be released in the future, spreading female infertility within local malaria-carrying mosquito populations and causing them to collapse.
In 2016, there were around 216 million malaria cases and an estimated 445,000 deaths worldwide, mostly of children under five years old.
Lead researcher Professor Andrea Crisanti, from the Department of Life Sciences at Imperial, said: “2016 marked the first time in over two decades that malaria cases did not fall year-on-year despite huge efforts and resources, suggesting we need more tools in the fight.”
World first: Suppressing a population
The team’s results, published today in Nature Biotechnology, represent the first time gene drive has been able to completely suppress a population, overcoming resistance issues previous approaches have faced.
Professor Crisanti added: “This breakthrough shows that gene drive can work, providing hope in the fight against a disease that has plagued mankind for centuries. There is still more work to be done, both in terms of testing the technology in larger lab-based studies and working with affected countries to assess the feasibility of such an intervention.
“It will still be at least 5-10 years before we consider testing any mosquitoes with gene drive in the wild, but now we have some encouraging proof that we’re on the right path. Gene drive solutions have the potential one day to expedite malaria eradication by overcoming the barriers of logistics in resource-poor countries.”
Targeting ‘doublesex‘: About the research methodology
The team targeted a gene in An. gambiae called ‘doublesex‘, which determines whether an individual mosquito develops as a male or as a female.
The team engineered a gene drive solution designed to selectively alter a region of the doublesex gene that is responsible for female development. Males who carried this modified gene showed no changes, and neither did females with only one copy of the modified gene. However, females with two copies of the modified gene showed both male and female characteristics, failed to bite and did not lay eggs.
Their experiments showed that the gene drive transmitted the genetic modification nearly 100% of the time. After eight generations no females were produced and the populations collapsed because of lack of offspring.
Previous attempts to develop gene drive for population suppression have encountered ‘resistance’, where targeted genes developed mutations that allowed the gene to carry out its function, but that that were resistant to the drive. These changes would then be passed down to the offspring, halting the gene drive in its tracks.
One of the reasons doublesex was picked for the gene drive target was that it was thought not to tolerate any mutations, overcoming this potential source of resistance. Indeed, in the study no functional mutated copy of the doublesex gene arose and spread in the population.
Next steps: Investigating the efficacy
While this is the first time resistance has been overcome, the team say additional experiments are needed to investigate the efficacy and the stability of the gene drive under confined laboratory settings that mimic tropical environments.
This involves testing the technology on larger populations of mosquitoes confined in more realistic settings, where competition for food and other ecological factors may change the fate of the gene drive.
The doublesex gene targeted in the study is similar across the insect world, although different insects have different exact genetic sequences. This suggests the technology could be used in the future to specifically target other disease-carrying insects.
Recent work from Imperial showed that suppressing An. gambiaepopulations in local areas is unlikely to affect the local ecosystem.
The Latest on: Gene drive
via Google News
The Latest on: Gene drive
- PGA Championship 2020: Was Collin Morikawa's drive on 16 the greatest shot in PGA history?on August 10, 2020 at 11:10 am
It's a shot that surely will be remembered for years to come. But where does it rank in PGA history? We explore ...
- Gene Therapy Market Trends Analysis, COVID-19 Impact, Key Players, Size Projection, Sales Statistics and Share Value By 2025on August 10, 2020 at 9:19 am
Gene Therapy Market Trends, Share and Size Analysis By Product (Kymriah, Luxturna, Yescarta, Zolgensma, Strimvelis, Zynteglo, Others), By Indication ...
- Lead poisoning could reduce gene expression in humanson August 7, 2020 at 6:26 am
Scientists have unveiled a correlation between high blood lead levels in children and methylation of genes involved in haem synthesis and carcinogenesis, indicating a previously unknown mechanism for ...
- Dr. Neville Sanjana receives 2020 Cancer Research Institute Technology Impact Awardon August 5, 2020 at 12:19 pm
Neville Sanjana, Ph.D., Core Faculty Member at the New York Genome Center, Assistant Professor of Biology, New York University, and Assistant Professor of Neuroscience and Physiology, NYU School of ...
- Gene Therapy Market to Reach $6.21 Billion by 2026: Allied Market Researchon August 5, 2020 at 7:27 am
According to the report, the global Gene Therapy Marketwas pegged at $393.35 million in 2018, and is projected to reach $6.21 billion by 2026, registering a CAGR of 34.8% from 2019 to 2026. The report ...
- How gene editing a person’s brain cells could be used to curb the opioid epidemicon August 5, 2020 at 5:28 am
A person dies of opioid overdose once every 13 minutes in the US. A researcher proposes a way using existing technology to remove the opioid target in people to prevent overdoses.
- uniQure Begins First AAV Gene Therapy Trial for Huntington’s Diseaseon August 4, 2020 at 4:07 pm
Gene therapy pioneer uniQure launched the first-in-human adeno ... in is important.” The next steps are to drive recruitment for this study, follow the patients and aggregate the data to learn whether ...
- Study identifies impact of gene mutations on severity of myelodysplastic syndromeon August 3, 2020 at 4:59 pm
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, led by Dr. Francesc Solé, has participated in the first international study that confirms that having two mutated ...
- Dynamical gene regulatory networks are tuned by transcriptional autoregulation with microRNA feedbackon July 31, 2020 at 2:15 am
Concepts from dynamical systems theory, including multi-stability, oscillations, robustness and stochasticity, are critical for understanding gene regulation during cell fate decisions, inflammation ...
via Bing News